DI NISIO, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 9.333
AS - Asia 5.518
EU - Europa 4.483
SA - Sud America 852
Continente sconosciuto - Info sul continente non disponibili 751
AF - Africa 105
OC - Oceania 12
Totale 21.054
Nazione #
US - Stati Uniti d'America 9.116
SG - Singapore 2.501
CN - Cina 1.385
IE - Irlanda 776
BR - Brasile 683
RU - Federazione Russa 675
UA - Ucraina 625
IT - Italia 558
VN - Vietnam 548
SE - Svezia 534
TR - Turchia 428
GB - Regno Unito 373
DE - Germania 301
FR - Francia 211
FI - Finlandia 178
IN - India 145
HK - Hong Kong 123
CA - Canada 100
BD - Bangladesh 80
AR - Argentina 69
MX - Messico 60
AT - Austria 46
ES - Italia 45
NL - Olanda 39
JP - Giappone 38
PL - Polonia 37
IQ - Iraq 34
ZA - Sudafrica 31
CO - Colombia 29
ID - Indonesia 29
EC - Ecuador 26
BE - Belgio 25
TW - Taiwan 23
PK - Pakistan 20
JM - Giamaica 18
PH - Filippine 17
CZ - Repubblica Ceca 15
KR - Corea 14
SA - Arabia Saudita 14
VE - Venezuela 14
JO - Giordania 13
MA - Marocco 13
EU - Europa 12
UZ - Uzbekistan 12
AU - Australia 11
EG - Egitto 11
IL - Israele 11
KE - Kenya 11
MY - Malesia 9
PY - Paraguay 9
TN - Tunisia 9
LT - Lituania 8
TH - Thailandia 8
AZ - Azerbaigian 7
IR - Iran 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
HN - Honduras 6
RO - Romania 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
KZ - Kazakistan 5
LB - Libano 5
PE - Perù 5
PS - Palestinian Territory 5
QA - Qatar 5
UY - Uruguay 5
DZ - Algeria 4
GT - Guatemala 4
KG - Kirghizistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
CG - Congo 3
CH - Svizzera 3
DK - Danimarca 3
EE - Estonia 3
GA - Gabon 3
HR - Croazia 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
PR - Porto Rico 3
SC - Seychelles 3
SR - Suriname 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
GR - Grecia 2
HU - Ungheria 2
KW - Kuwait 2
SN - Senegal 2
SV - El Salvador 2
TL - Timor Orientale 2
AI - Anguilla 1
AM - Armenia 1
Totale 20.291
Città #
Singapore 1.775
Chandler 1.002
San Jose 906
Jacksonville 865
Dublin 764
Ashburn 641
Dallas 397
Princeton 393
Council Bluffs 344
Beijing 335
Izmir 271
Los Angeles 217
Nanjing 216
Santa Clara 206
Ho Chi Minh City 199
Altamura 184
Southend 177
Wilmington 169
Cambridge 137
Dearborn 132
The Dalles 118
Hong Kong 113
Hanoi 109
Boardman 94
Houston 84
Ann Arbor 83
New York 81
Buffalo 80
Tongling 76
São Paulo 75
Nanchang 71
Woodbridge 68
Helsinki 62
Chieti 61
Redondo Beach 61
Moscow 53
Munich 50
Kunming 47
Hebei 46
Orem 44
Phoenix 40
Seattle 40
Shenyang 36
Tianjin 36
Washington 36
Atlanta 35
Jiaxing 34
Tokyo 34
Warsaw 33
Brooklyn 31
Dong Ket 31
Montreal 30
Chicago 29
Vienna 29
Hefei 28
Nuremberg 28
Denver 27
Haiphong 26
Pescara 26
Changsha 25
San Francisco 25
Chennai 24
London 24
Poplar 24
Brussels 23
Columbus 23
Milan 23
Rome 23
St Louis 23
Frankfurt am Main 22
Norwalk 22
Boston 20
Baghdad 19
Da Nang 19
Guangzhou 19
Johannesburg 19
Manchester 19
Mexico City 19
Rio de Janeiro 19
Hangzhou 18
Amsterdam 17
Shanghai 17
Stockholm 16
Fairfield 14
Pune 14
Toronto 14
Amman 13
Biên Hòa 13
Brasília 13
Falls Church 13
Leawood 13
Mumbai 13
Ankara 12
Dhaka 12
Guayaquil 12
Taipei 12
Turku 12
Belo Horizonte 11
Buenos Aires 11
Grevenbroich 11
Totale 12.130
Nome #
Anticoagulant therapy for splanchnic vein thrombosis: ISTH SSC Subcommittee Control of Anticoagulation 375
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study 246
Medication review interventions to reduce hospital readmissions in older people 224
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques. 175
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study 172
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 171
Supportive management strategies for disseminated intravascular coagulation: An international consensus 168
24 weeks of Pilates-aerobic and educative training to improve body fat mass in elderly Serbian women 163
Circulating leptin is associated with oxidized LDL in postmenopausal women. 142
Microsatellite polymorphism of the human leptin gene (LEP) and risk of cardiovascular disease 136
Treatment of Lower Extremity Superficial Thrombophlebitis 135
Soluble thrombomodulin and vascular adhesion molecule-1 are associated to leptin plasma levels in obese patients. 134
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review 134
Effects of multiple inherited and acquired thrombophilia on outcomes of in-vitro fertilization 133
Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy. 132
A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC 131
Thrombophilia and outcomes of assisted reproduction technologies: a systematic review and meta-analysis 130
Arterial Thrombosis in ambulatory cancer patients treated with chemotherapy. 129
Low-Dose Subcutaneous Tocilizumab to Prevent Disease Progression in Patients with Moderate COVID-19 Pneumonia and Hyperinflammation 128
Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. 127
Non-O blood group and outcomes of in vitro fertilization 127
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation 127
Dementia in patients with atrial fibrillation and the value of the Hachinski ischemic score 126
ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer 126
Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation 126
Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity 126
Acute complications and mortality in hospitalized patients with coronavirus disease 2019: A systematic review and meta-analysis 125
Bleeding and venous thromboembolic events in patients with active cancer hospitalized for an acute medical illness 124
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 123
Recanalization rate in patients with proximal vein thrombosis treated with the direct oral anticoagulants 123
Association of Factor VII Levels With Inflammatory Parameters in Hypercholesterolemic Patients. 121
Identification of three genetic risk factors for venous thrombosis using a multiplex allele-specific PCR assay: comparison of conventional and new alternative methods for the preparation of DNA from clinical samples 121
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world: Actual use of low-molecular-weight heparin in cancer 121
Computerised cognitive training for preventing dementia in people with mild cognitive impairment 120
Anticoagulant therapy for splanchnic vein thrombosis: a systematic review and meta-analysis 120
Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study 119
Low-molecular-weight heparin for the treatment of acute venous thromboembolism in patients with active cancer 119
Edoxaban for the treatment of cancer-associated venous thromboembolism 119
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 119
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 119
Deep vein thrombosis and pulmonary embolism 118
Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy 117
Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia 117
Whole-Arm ultrasound for suspected upper-extremity deep venous thrombosis in outpatients 116
Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis 116
A clinical decision rule and D-dimer testing to rule out upper extremity deep vein thrombosis in high-risk patients 115
Current management strategies and long-term clinical outcomes of upper extremity venous thrombosis 115
Effects of body composition on the procoagulant imbalance in obese patients 115
Asymptomatic venous thromboembolism in patients with solid tumors treated with chemotherapy: An underestimated phenomenon 113
Rivaroxaban for cancer-associated cardiac thrombosis 113
Edoxaban for treatment of venous thromboembolism in patients with cancer: Rationale and design of the hokusai VTE-cancer study 112
Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: A systematic review and meta-analysis 112
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysis 111
Improving the diagnostic management of upper extremity deep vein thrombosis 111
Impact of concomitant antiplatelet therapy on the efficacy and safety of direct oral anticoagulants for acute venous thromboembolism: Systematic review and meta-analysis 111
Safety and efficacy of low-dose fondaparinux (1.5mg) for the prevention of venous thromboembolism in acutely ill medical patients with renal impairment: The FONDAIR study 110
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH 109
Use of heparins in patients with cancer: Individual participant data metaanalysis of randomised trials study protocol 109
The hematocrit and platelet target in polycytemia vera 108
Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses 108
Cannabinoids for medical use: A systematic review and meta-analysis 108
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 108
The diagnostic management of upper extremity deep vein thrombosis: A review of the literature 108
Management of venous thromboembolism in cancer patients: Considerations about the clinical practice guideline update of the American society of clinical oncology 108
Long-term clinical outcomes of splanchnic vein thrombosis results of an international registry 108
Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis 108
Antithrombotic therapy and cancer 107
Trasforming growth factor-beta 1 levels in hypertensive patients: association with body mass index and leptin. 106
Direct oral anticoagulant plasma levels in hospitalized COVID-19 patients treated with dexamethasone 106
A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism 105
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife 105
Frailty phenotype as a predictor of bleeding and mortality in ambulatory patients receiving direct oral anticoagulants 104
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis 103
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts 103
Incidental pulmonary embolism in cancer patients: Interobserver agreement on the diagnosis and extent with a focus on distal clots 102
Cancer-associated unsuspected pulmonary embolism 102
Splanchnic vein thrombosis: Current perspectives 102
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer 102
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 101
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists 101
Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance 101
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study 101
Transforming growth factor-β1 levels in hypertensive patients: association with body mass index and leptin 101
Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients 101
Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis 100
Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis 100
Clinical course of isolated distal deep vein thrombosis in patients with active cancer: A multicenter cohort study 100
D-Dimer test in cancer patients with suspected acute pulmonary embolism 100
NLRP3 inflammasome and interleukin-1 contributions to COVID-19-associated coagulopathy and immunothrombosis 99
Treatment for superficial infusion thrombophlebitis of the upper extremity. 99
Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life 98
Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study 98
D-Dimer Test In Cancer Patients With Suspected Acute Pulmonary Embolism 98
Effects of Obesity and Thrombophilia on the Risk of Abortion in Women Undergoing In Vitro Fertilization 98
Prevention of catheter-related venous thrombosis with nadroparin in patients receiving high dose chemotherapy for hematological malignancies, a randomized placebo controlled study 97
Obesity, Poor Muscle Strength and the Risk of Venous Thromboembolism in Older Persons: the InCHIANTI Study 97
Prognostic nutritional index in elderly patients hospitalized for acute heart failure 97
Inhaled analgesia for pain management in labour 97
Decision analysis for cancer screening in idiopathic venous thromboembolism 96
Safety and feasibility of diagnostic algorithm combining clinical probability, D-dimer and ultrasonography in suspected upper extremity deep vein thrombosis: a prospective management study. 96
Totale 12.063
Categoria #
all - tutte 93.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022738 0 0 9 116 35 27 31 65 53 22 107 273
2022/20232.957 249 388 133 308 328 586 156 227 384 43 95 60
2023/20241.286 98 45 141 48 106 373 254 49 27 39 5 101
2024/20252.995 200 619 402 63 52 98 76 250 345 130 353 407
2025/20267.009 506 273 772 855 718 403 1.128 484 813 670 300 87
2026/20271.311 413 706 192 0 0 0 0 0 0 0 0 0
Totale 21.054